BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL

被引：6
|
作者：
Sandhu, Roopinder K. [1 ]
Ezekowitz, Justin [1 ]
Andersson, Ulrika [1 ]
Alexander, John [1 ]
Granger, Christopher [1 ]
Halvorsen, Sigrun [1 ]
Hanna, Michael [1 ]
Hijazi, Ziad [1 ]
Jansky, Petr [1 ]
Lopes, Renato [1 ]
Wallentin, Lars [1 ]
机构：
[1] Univ Alberta, Edmonton, AB, Canada
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(15)60284-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1270M-07
引用
下载
收藏
页码：A284 / A284
页数：1
相关论文
共 50 条
  • [21] APIXABAN VERSUS WARFARIN FOR PATIENTS WITH RECENT ONSET ATRIAL FIBRILLATION: INSIGHTS FROM THE ARISTOTLE TRIAL
    Guimaraes, Patricia
    Alexander, John
    Wojdyla, Daniel
    Thomas, Laine
    Alings, Marco
    Flaker, Greg
    Al-Khatib, Sana
    Hanna, Michael
    Wallentin, Lars
    Granger, Christopher
    Lopes, Renato
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 691 - 691
  • [22] Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial
    Alexander, Karen P.
    Brouwer, Marc A.
    Mulder, Hillary
    Vinereanu, Dragos
    Lopes, Renato D.
    Proietti, Marco
    Al-Khatib, Sana M.
    Hijazi, Ziad
    Halvorsen, Sigrun
    Hylek, Elaine M.
    Verheugt, Freek W. A.
    Alexander, John H.
    Wallentin, Lars
    Granger, Christopher B.
    AMERICAN HEART JOURNAL, 2019, 208 : 123 - 131
  • [23] Apixaban versus Warfarin in Atrial Fibrillation REPLY
    Mega, Jessica L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (01): : 89 - 90
  • [24] Apixaban versus warfarin in Patients with Atrial Fibrillation in relation to Prior Warfarin Use: Insights from the ARISTOTLE trial
    Garcia, David A.
    Alexander, John H.
    Lopes, Renato D.
    Thomas, Laine
    Yang, Hongqiu
    Ansell, Iack
    Commerford, Patrick
    Flaker, Greg
    Lanas, Fernando
    Mohan, Puneet
    Vinereanu, Dragos
    Xavier, Denis
    Granger, Christopher
    Wallentin, Lars
    CIRCULATION, 2012, 126 (21)
  • [25] ARISTOTLE reveals superiority of apixaban over warfarin in patients with atrial fibrillation
    Bryony M. Mearns
    Nature Reviews Cardiology, 2011, 8 (11) : 607 - 607
  • [26] Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight Insights From the ARISTOTLE Trial
    Hohnloser, Stefan H.
    Fudim, Marat
    Alexander, John H.
    Wojdyla, Daniel M.
    Ezekowitz, Justin A.
    Hanna, Michael
    Atar, Dan
    Hijazi, Ziad
    Cecilia Bahit, M.
    Al-Khatib, Sana M.
    Luis Lopez-Sendon, Jose
    Wallentin, Lars
    Granger, Christopher B.
    Lopes, Renato D.
    CIRCULATION, 2019, 139 (20) : 2292 - 2300
  • [27] Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
    Wallentin, Lars
    Hijazi, Ziad
    Andersson, Ulrika
    Alexander, John H.
    De Caterina, Raffaele
    Hanna, Michael
    Horowitz, John D.
    Hylek, Elaine M.
    Lopes, Renato D.
    Asberg, Signild
    Granger, Christopher B.
    Siegbahn, Agneta
    CIRCULATION, 2014, 130 (21) : 1847 - +
  • [28] Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial
    Focks, Jeroen Jaspers
    Brouwer, Marc A.
    Wojdyla, Daniel M.
    Thomas, Laine
    Lopes, Renato D.
    Washam, Jeffrey B.
    Lanas, Fernando
    Xavier, Denis
    Husted, Steen
    Wallentin, Lars
    Alexander, John H.
    Granger, Christopher B.
    Verheugt, Freek W. A.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 353
  • [29] Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Left Ventricular Hypertrophy Insights From the ARISTOTLE Trial
    Al-Khatib, Sana M.
    Mulder, Hillary
    Wojdyla, Daniel
    Lopes, Renato D.
    Wallentin, Lars
    Alexander, John H.
    Hijazi, Ziad
    Goto, Shinya
    Granger, Christopher B.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2021, 14 (03): : 359 - 361
  • [30] Pharmacoeconomic aspects of apixaban for prevention of thromboembolic events in patients with atrial fibrillation
    Rudakova, A. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2015, 11 (01) : 60 - 62
12345